Empower Advisory Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $421K | Sell |
6,093
-4,549
| -43% | -$314K | ﹤0.01% | 346 |
|
|
2025
Q1 | $739K | Sell |
10,642
-1,809
| -15% | -$126K | ﹤0.01% | 267 |
|
|
2024
Q4 | $1.07M | Sell |
12,451
-280
| -2% | -$24.1K | ﹤0.01% | 232 |
|
|
2024
Q3 | $1.52M | Sell |
12,731
-289
| -2% | -$34.4K | 0.01% | 209 |
|
|
2024
Q2 | $1.86M | Buy |
13,020
+77
| +0.6% | +$11K | 0.01% | 202 |
|
|
2024
Q1 | $1.66M | Buy |
12,943
+948
| +8% | +$122K | 0.01% | 210 |
|
|
2023
Q4 | $1.24M | Buy |
11,995
+1,582
| +15% | +$164K | ﹤0.01% | 225 |
|
|
2023
Q3 | $947K | Sell |
10,413
-1,333
| -11% | -$121K | ﹤0.01% | 233 |
|
|
2023
Q2 | $950K | Buy |
11,746
+450
| +4% | +$36.4K | ﹤0.01% | 238 |
|
|
2023
Q1 | $901K | Buy |
+11,296
| New | +$901K | ﹤0.01% | 247 |
|